InvestorsObserver
×
News Home

Do Traders Think Indaptus Therapeutics Inc (INDP) Can Turn Around Thursday?

Thursday, June 01, 2023 03:36 PM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Indaptus Therapeutics Inc (INDP) Can Turn Around Thursday?

Indaptus Therapeutics Inc (INDP) stock has fallen 10.77% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Indaptus Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on INDP!

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With INDP Stock Today?

Indaptus Therapeutics Inc (INDP) stock is trading at $1.74 as of 1:39 PM on Thursday, Jun 1, a rise of $0.11, or 6.75% from the previous closing price of $1.63. The stock has traded between $1.63 and $1.82 so far today. Volume today is light. So far 32,043 shares have traded compared to average volume of 50,966 shares. To see InvestorsObserver's Sentiment Score for Indaptus Therapeutics Inc click here. Click Here to get the full Stock Report for Indaptus Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App